CN1062753C - Medicine for preventing and treating eye diseases - Google Patents

Medicine for preventing and treating eye diseases Download PDF

Info

Publication number
CN1062753C
CN1062753C CN97109276A CN97109276A CN1062753C CN 1062753 C CN1062753 C CN 1062753C CN 97109276 A CN97109276 A CN 97109276A CN 97109276 A CN97109276 A CN 97109276A CN 1062753 C CN1062753 C CN 1062753C
Authority
CN
China
Prior art keywords
medicine
portions
radix
preventing
eye diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97109276A
Other languages
Chinese (zh)
Other versions
CN1177492A (en
Inventor
陈新学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97109276A priority Critical patent/CN1062753C/en
Publication of CN1177492A publication Critical patent/CN1177492A/en
Application granted granted Critical
Publication of CN1062753C publication Critical patent/CN1062753C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a medicine for preventing and treating eye diseases, particularly to a medicine for preventing and treating acute contagious conjunctivitis. The medicine comprises the following components by weight proportion: 3.5 to 20 portions of chrysanthemum or dandelion, 3.5 to 20 portions of forsythia fruit, 3.5 to 20 portions of honeysuckle flower or isatis root, 3 to 11 portions scutellaria root or phellodendron bark, 3 to 11 portions of liner grass, 3 to 11 portions of raw xiangjie or senna, 3.5 to 20 portions of mulberry bark and 2 to 10 portions of mint or lophatherum. The present invention can effectively prevent and treat eye diseases and treat acute and epidemic contagious conjunctivitis.

Description

The medicine of control disease of eye
The present invention relates to a kind of medicine of preventing and treating disease of eye, especially prevent and treat the medicine of pink eye disease.
Existing Chinese medicine is is especially prevented and treated acute or epidemic acute conjunctivitis (claiming acute catarrhal conjunctivitis again) often produces effects very little for prevention, treatment pink eye disease.
The purpose of this invention is to provide a kind of medicine of preventing and treating disease of eye, it can effectively prevent disease of eye, effects a radical cure acute or epidemic acute conjunctivitis.
The technical scheme that realizes the object of the invention is: a kind of medicine of preventing and treating disease of eye, mainly form by the Chinese crude drug of following weight percentage ratio: Flos Chrysanthemi or Herba Taraxaci 3.5~20, Fructus Forsythiae 3.5~20, Flos Lonicerae or Radix Isatidis 3.5~20, Radix Scutellariae or Cortex Phellodendri 3~11, Radix Gentianae 3~11, ← Folium Sennae 3~11, Cortex Mori 3.5~20, Herba Menthae or Herba Lophatheri 2~10.
And, can also contain (percentage by weight): Radix Bupleuri 3.5~20, Fructus Gardeniae 3~11, Radix Angelicae Sinensis 3~11, Periostracum Cicadae 2~7, Radix Glycyrrhizae 2~7, Radix Paeoniae Rubra 3~11, the Radix Rehmanniae 3.5~20.
The present invention has the effect of wind and heat dispersing pathogenic fire purging, improving acuity of vision and removing nebula, can effectively prevent disease of eye, treat acute, epidemic acute conjunctivitis, acute conjunctivitis, acute hemorrhagic conjunctivitis, also control diseases such as vernal conjunctivitis, show through clinical use, this medicine effective percentage is 99%, and cure rate is 95%.
Below be various embodiments of the present invention (content all is weight percentage):
Figure 9710927600031
Embodiments of the invention can also be,
The described Flos Chrysanthemi of the foregoing description, Flos Lonicerae, Radix Scutellariae ← and Herba Menthae can replace with Herba Taraxaci, Radix Isatidis, Cortex Phellodendri, Folium Sennae and Herba Lophatheri respectively and effect is basic identical.Described Flos Chrysanthemi is Flos Chrysanthemi Indici preferably.
This medicine is oral medicine, can adopt existing Chinese medicine preparation technology (referring to combined publication society of Beijing Medical University " Chinese medicine " chapter 9 in publication in August nineteen ninety-five) batch machining to become pill, powder, tablet, electuary or glue to assist.Also can make the dosage form of teabag (medicine) formula, be encapsulated in the pouch made from clean filter paper after promptly the medicine of preparation being pulverized, when drinking, only need pouch is put in the cup, as the mode of drinking tea be steeped drink with boiling water.
More than each agent all can be equipped with a small amount of additive that improves mouthfeel in right amount, as sugar, honey, aroma type gourmet powder etc., especially when making electuary, teabag (medicine), can pay attention to.Meanwhile, when adopting additive, should avoid selecting for use the incompatible compatibility of Chinese medicine, specifically can be referring to aforementioned " Chinese medicine " chapter 8.
This medicine is except that above-mentioned effect, and for eye health, preventing and treating pink eye disease, trachoma, glaucoma, presbyopia and nearly hypermetropia etc. all has effect preferably.

Claims (2)

1. a medicine of preventing and treating disease of eye mainly is made up of the Chinese medicinal components of following weight percentage ratio: Flos Chrysanthemi or Herba Taraxaci 3.5~20, Fructus Forsythiae 3.5~20, Flos Lonicerae or Radix Isatidis 3.5~20, Radix Scutellariae or Cortex Phellodendri 3~11, Radix Gentianae 3~11, Folium Sennae 3~11, Cortex Mori 3.5~20, Herba Menthae or Herba Lophatheri 2~10.
2. medicine according to claim 1 is characterized in that also containing the Chinese medicinal components of following weight percentage ratio: Radix Bupleuri 3.5~20, Fructus Gardeniae 3~11, Radix Angelicae Sinensis 3~11, Periostracum Cicadae 2~7, Radix Glycyrrhizae 2~7, Radix Paeoniae Rubra 3~11, the Radix Rehmanniae 3.5~20.
CN97109276A 1997-10-21 1997-10-21 Medicine for preventing and treating eye diseases Expired - Fee Related CN1062753C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97109276A CN1062753C (en) 1997-10-21 1997-10-21 Medicine for preventing and treating eye diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97109276A CN1062753C (en) 1997-10-21 1997-10-21 Medicine for preventing and treating eye diseases

Publications (2)

Publication Number Publication Date
CN1177492A CN1177492A (en) 1998-04-01
CN1062753C true CN1062753C (en) 2001-03-07

Family

ID=5171081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97109276A Expired - Fee Related CN1062753C (en) 1997-10-21 1997-10-21 Medicine for preventing and treating eye diseases

Country Status (1)

Country Link
CN (1) CN1062753C (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP2108370A1 (en) 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
EP1631304A4 (en) 2003-04-04 2007-03-21 Unigen Pharmaceuticals Inc Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
KR100761248B1 (en) * 2006-10-12 2007-10-04 주식회사 유니젠 Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
CN101095763B (en) * 2007-07-16 2012-07-04 罗连珍 Decoction medicine for treating acute catarrhal conjunctivitis and method for preparing the same
CN101199619B (en) * 2007-12-12 2011-03-23 陈德顺 Oral administration Chinese medicine for treating chronic conjunctivitis
CN102512603B (en) * 2011-12-23 2013-12-25 崔红梅 Traditional Chinese medicinal composition for treating acute infectious conjunctivitis
CN103006828A (en) * 2012-11-29 2013-04-03 董德华 Medicinal composition for treating conjunctivitis
CN104189607A (en) * 2014-09-19 2014-12-10 刘玉美 Chinese medicinal preparation for treating viral conjunctivitis
CN104940384B (en) * 2015-07-17 2017-11-03 江苏苏南药业实业有限公司 It is a kind of to treat Chinese medicine composition of conjunctivitis and preparation method thereof
CN105106703A (en) * 2015-09-02 2015-12-02 宋琳 Traditional Chinese medicine preparation for treating acute catarrhal conjunctivitis and nursing method
CN105833207A (en) * 2016-06-16 2016-08-10 杨艳艳 Traditional Chinese medicine preparation for treating chronic conjunctivitis
CN107551008A (en) * 2017-10-16 2018-01-09 王继显 One kind treats conjunctivitis Chinese medicine preparation
CN111346191A (en) * 2018-12-24 2020-06-30 智德明创生物科技(北京)有限公司 Traditional Chinese medicine eye patch for treating meibomian gland dysfunction xerophthalmia and preparation method thereof
CN109620531A (en) * 2019-01-31 2019-04-16 山西博瑞建明科技有限公司 A kind of sustained-release administration alleviates the glasses cutting ferrule of eye disease
CN112245491A (en) * 2019-07-02 2021-01-22 河南中立生物科技有限公司 Traditional Chinese medicine eye drop and preparation method thereof
CN110522815A (en) * 2019-09-23 2019-12-03 潘继光 A kind of Chinese medicine composition and preparation method thereof for treating disease of eye

Also Published As

Publication number Publication date
CN1177492A (en) 1998-04-01

Similar Documents

Publication Publication Date Title
CN1062753C (en) Medicine for preventing and treating eye diseases
CN102293303B (en) Fire-clearing health-care tea
CN102697830B (en) Pharmaceutical composition for preventing and treating menstrual disease and preparation method and application of composition
CN1203805A (en) Health-care drink capable of preventing and curing menopathy
CN1116536A (en) Chinese medicinal herb preparation for prevention and treatment of poultry and animal diseases
CN106551056A (en) A kind of Flos Trollii solid herbal tea beverage and preparation method thereof
CN1070825A (en) The prescription of anti-intoxication alcohol neutralizing oral agents and manufacture method
CN101954028A (en) Medicinal pillow for preventing and treating myopic eyes
CN101297889A (en) Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof
CN1085441A (en) The lengthen one's life manufacture method of tea of Chinese herbal medicine detoxifcation
CN103656499B (en) A kind of Traditional Chinese drug mixture treating cystic polyp and preparation method thereof
CN101297899A (en) Chinese medicine preparation for treating acute mammitis of cow and method of preparing the same
CN100393335C (en) Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, aversion to light, swell pain and its manufacturing method
CN104432337A (en) Drink capable of clearing heat and removing toxicity
CN101129512A (en) Zegui oral liquid
CN103156030A (en) Stomach-invigorating tea and preparation method thereof
CN100394938C (en) Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, swell pain and its manufacturing method
CN1141962C (en) Medicine for treating psoriasis
CN101129645A (en) Anti-inflammation detoxication drink
CN101843723A (en) Chinese medicament for treating abnormal menstruation
CN104606105A (en) Plant nanoemulsion toothpaste
CN1491589A (en) Disease-proof health drink and its producing process
CN1085095A (en) A kind of inhalation and production method thereof
CN1426779A (en) Chinese medicine raw material in form of particles and its preparation method
CN1110156A (en) Bianxueting oral liquor for curing hematochezia

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee